68 results
8-K
EX-1.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall
8-K
EX-10.2
ADIL
Adial Pharmaceuticals Inc
18 Jan 24
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
4:15pm
, intellectual property, facilities and HR, and partner with CEO to align functions with Adial’s corporate objectives and overall plan targets both near
8-K
EX-99.1
ADIL
Adial Pharmaceuticals Inc
11 Sep 23
Regulation FD Disclosure
6:03am
of AD04 assuming a successful regulatory outcome Primary Targets - companies with commercial capabilities or pipeline development capabilities … in: Alcohol Therapeutics, Addiction, Psychiatry, Neurology, and niche Orphan CNS Secondary Targets - companies focused on DTP (Direct to Patient) and DTC
424B3
futtr7akbw4mihew4hz
28 Jul 23
Prospectus supplement
6:13pm
8-K
EX-99.1
0k8q hf8yl4w8c
9 Jun 23
Regulation FD Disclosure
12:15pm
POS AM
iw72k
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
POS AM
13t6 fyv5
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
8-K
EX-99.1
kyzgk
16 May 22
Adial Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
9:25am
424B3
e4qyd8
12 Apr 22
Prospectus supplement
4:15pm
424B5
974jdpi7121jp
14 Feb 22
Prospectus supplement for primary offering
4:55pm
424B3
v2vumu9 vs0h9ybjuu
17 Dec 21
Prospectus supplement
12:00am